EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy

Abdo Meyiah, Faez Iqbal Khan, Dia Aldeen Alfaki, Khaled Murshed, Afsheen Raza, Eyad Elkord

Translational Oncology · 2025-03 · 53 · 102307

DOI: 10.1016/j.tranon.2025.102307 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Translational Oncology, 2025-03. Verfasst von Abdo Meyiah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioinformatics & Suzhou Municipal Key Lab of Biomedical Sciences and Translational Immunology, School of Science, Xi'an…. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a common cancer with high mortality rates. Despite progress in treatment, it remains an incurable disease for many patients. In CRC, the tumor microenvironment (TME) plays critical roles in tumor growth, progression, patients' prognosis, and response to treatments. Understanding TME complexities is important for developing effective therapies. In vitro and in vivo preclinical models are critical in understanding the disease, discovering potential targets, and developing effective therapeutics. In this review, we focus on preclinical research studies associated with modulation of the TME in CRC. These models give insights into understanding the role of stroma and immune cell components of the TME in CRC and improve clinical responses, providing insights in novel treatment options. Various studies have focused on targeting the TME in CRC to improve responses to different therapeutic approaches. These include identifying targets for cancer therapies, targeting molecular signaling, and enhancing the efficacy of immunotherapeutic modalities. Furthermore, targeting stromal and angiogenic factors in the TME may provide new therapeutic options. Overall, understanding and targeting the TME in CRC is a promising approach for improving therapeutic outcomes.

Schlagwörter

Stichwörter der Autor:innen

CRCCancer therapyPreclinical modelsTumor microenvironment

Autor:innen und Institutionen

  • Department of Biosciences and Bioinformatics & Suzhou Municipal Key Lab of Biomedical Sciences and Translational Immunology, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China.
  • Department of Haematology, Al-Zaeim Al-Azhari University, Khartoum, Sudan.
  • Department of Pathology, Hamad Medical Corporation, Doha, Qatar.
  • College of Health Sciences, Abu Dhabi University, Abu Dhabi, United Arab Emirates.
  • Department of Biosciences and Bioinformatics & Suzhou Municipal Key Lab of Biomedical Sciences and Translational Immunology, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China; College of Health Scien…

Zitieren

APA

Meyiah, A., Khan, F. I., Alfaki, D. A., Murshed, K., Raza, A., & Elkord, E. (2025). The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy. Translational Oncology, 53, 102307. https://doi.org/10.1016/j.tranon.2025.102307

Vancouver

Meyiah A, Khan FI, Alfaki DA, Murshed K, Raza A, Elkord E. The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy. Translational Oncology. 2025;53:102307. doi:10.1016/j.tranon.2025.102307

BibTeX
@article{Meyiah2025,
  author = {Meyiah, Abdo and Khan, Faez Iqbal and Alfaki, Dia Aldeen and Murshed, Khaled and Raza, Afsheen and Elkord, Eyad},
  title = {The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy},
  journal = {Translational Oncology},
  year = {2025},
  volume = {53},
  pages = {102307},
  doi = {10.1016/j.tranon.2025.102307}
}
Kostenlos starten →